Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cefazolin versus cefazolin sodium pentahydrate for pediatric infection
ChiCTR1800017572Phase 4Not yet recruiting
- Sponsor
- Children's Hospital of Fudan University
- Start
- Sep 2018
- Modality
- Reversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of cefazolin in Infection (2 arms), sponsored by Children's Hospital of Fudan University. Primary endpoints: Symptoms and Bacteriological examination. Planned start Sep 2018; status: not yet recruiting.
02
Drugs
cefazolin
03
Conditions
Infection
Beyond the preview
Go deeper on ChiCTR1800017572.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800017572.